Article Text

A4.11 Syndecan-4 is an important player in regulating the WNT signalling pathway in articular cartilage
  1. C Clarke1,
  2. A Held1,
  3. R Stange2,
  4. G Nalesso3,
  5. J Sherwood1,
  6. U Hansen1,
  7. L Godmann1,
  8. F Echtermeyer4,
  9. F Dell’Accio4,
  10. T Pap1,
  11. J Bertrand1
  1. 1Institute for Experimental Musculoskeletal Medicine, University Hospital Münster, Münster
  2. 2Department of Trauma, Hand and Reconstructive Surgery; University Hospital Muenster, Germany
  3. 3Centre for Experimental Medicine and Rheumatology Queen Mary London, UK
  4. 4Department of Anaesthesiology and Intensive Care Medicine, Medical School Hanover, Germany


Background The heparan sulfate proteoglycan syndecan-4 (Sdc4) is a regulator of various cartilage-related processes including osteoarthritis (OA). Blockade of Sdc4 signalling protects mice from cartilage degradation in experimentally induced OA. OA is characterised by matrix remodelling and hypertrophic differentiation of chondrocytes. Various signalling pathways including the WNT signalling pathway have been implicated to trigger this change of chondrocyte phenotype. Experiments investigating the effect of different WNT3a concentrations on chondrocytes have emphasised a complex dialogue between canonical and non-canonical WNT pathways. We hypothesise that Sdc4 controls the chondrocyte phenotype by specific modulation of WNT signalling pathways.

Methods In vitro analyses were performed using neonatal wild type (wt) and Sdc4-/- chondrocytes, or blocking antibodies against Sdc4. The influence of WNT3a on glycosaminoglycan (GAG) production was analysed using alcian blue staining of micromass cultures. Expression of marker genes (e.g. aggrecan, collagen2, MMP13) was measured by quantitative RT-PCR. Effects of WNT3a on canonical and non canonical WNT signalling were analysed using Western Blot (ß-catenin and pCamKII) and luciferase reporter assay (TCF/Lef). In vivorelevance was investigated upon induction of OA using the DMM model.

Results Micromass cultures revealed a higher basal GAG production by Sdc4-/- chondrocytes. WNT3a stimulation led to a decrease in GAG production in wt cells, which was absent in Sdc4-/- chondrocytes. qRT-PCR showed a 10x higher basal production of aggrecan and collagen2 in Sdc4-/- chondrocytes. WNT3a increased the expression of both genes in Sdc-4 -/-, whereas decreasing the expression in wt chondrocytes. MMP13 was significantly less expressed in Sdc4-/- chondrocytes and, unlike in wt cells, was not up regulated upon WNT3a stimulation. Western blot showed that ß-catenin is not up regulated upon stimulation with WNT3a in Sdc4-/- chondrocytes. LRP6 was less phosphorylated and TCF/Lef promotor was less activated upon WNT3a stimulation in Sdc4-/- chondrocytes. pCamKII was increased under basal conditions, but decreased upon WNT3a stimulation in Sdc4-/-. The same effects on canonical and non canonical WNT signalling upon WNT stimulation were obtained by using a blocking anti-Sdc-4 antibody. In vivo stainings confirmed in vitro results.

Conclusion Sdc4 is a major regulator of cellular response to WNT signals through facilitating the induction of the canonical WNT signalling pathway. The blockade of Sdc4 protects from OA induced changes in chondrocyte phenotype by inhibiting WNT induced differentiation of chondrocytes.

Statistics from

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.